Jennison Associates
ASMB icon

Jennison Associates’s Assembly Biosciences ASMB Stock Holding History

Jennison Associates’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-196,784
Closed -$38.8M – 645
2020
Q3 		$38.8M Buy
196,784
+678
+0.3% +$171K 0.03% 224
2020
Q2 		$54.9M Buy
196,106
+1,037
+0.5% +$242K 0.05% 151
2020
Q1 		$34.7M Sell
195,069
-474
-0.2% -$102K 0.04% 183
2019
Q4 		$48M Buy
195,543
+511
+0.3% +$94.1K 0.05% 193
2019
Q3 		$23M Sell
195,032
-17,938
-8% -$2.71M 0.02% 298
2019
Q2 		$34.5M Buy
212,970
+6,880
+3% +$1.31M 0.03% 263
2019
Q1 		$48.7M Sell
206,090
-259
-0.1% -$65.6K 0.05% 230
2018
Q4 		$56M Sell
206,349
-83
-0% -$24K 0.06% 188
2018
Q3 		$92M Buy
206,432
+464
+0.2% +$217K 0.08% 155
2018
Q2 		$96.9M Buy
205,968
+3,031
+1% +$1.6M 0.09% 150
2018
Q1 		$120M Buy
202,937
+26,245
+15% +$16.3M 0.12% 128
2017
Q4 		$95.9M Buy
176,692
+28,919
+20% +$13.1M 0.09% 162
2017
Q3 		$61.9M Sell
147,773
-15,010
-9% -$4.6M 0.06% 244
2017
Q2 		$40.3M Sell
162,783
-5,178
-3% -$1.46M 0.04% 300
2017
Q1 		$51.4M Sell
167,961
-5,192
-3% -$1.27M 0.06% 258
2016
Q4 		$25.2M Buy
173,153
+3,983
+2% +$592K 0.03% 382
2016
Q3 		$14.6M Sell
169,170
-625
-0.4% -$48.3K 0.02% 445
2016
Q2 		$11.3M Sell
169,795
-164
-0.1% -$10.8K 0.01% 462
2016
Q1 		$10.2M Buy
169,959
+1,136
+0.7% +$76K 0.01% 457
2015
Q4 		$15.2M Buy
168,823
+541
+0.3% +$58.9K 0.01% 447
2015
Q3 		$19.3M Buy
168,282
+859
+0.5% +$151K 0.02% 438
2015
Q2 		$38.7M Buy
167,423
+1,096
+0.7% +$211K 0.04% 381
2015
Q1 		$26.4M Buy
166,327
+91,834
+123% +$12.4M 0.02% 412
2014
Q4 		$7.03M Buy
74,493
+41,160
+123% +$4.06M 0.01% 497
2014
Q3 		$3.28M Hold
33,333
– – ﹤0.01% 542
2014
Q2 		$2.62M Buy
+33,333
New +$2.36M ﹤0.01% 551

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Jennison Associates's ASMB Position: Q4 2020 in Review

Jennison Associates sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 196,784 shares — an estimated $38.8M sold.

Jennison Associates first reported a position in ASMB in Q2 2014 and held it in 26 quarters. The position peaked at $120M in Q1 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Jennison Associates reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Jennison Associates sold 196,784 Assembly Biosciences shares in Q4 2020, an estimated $38.8M.
  • Jennison Associates first reported a position in Assembly Biosciences in Q2 2014 and held it in 26 quarters.
  • Jennison Associates's Assembly Biosciences position peaked at $120M in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.